Business Description
Well Lead Medical Co Ltd
ISIN : CNE1000021C2
Share Class Description:
SHSE:603309: Class ACompare
Compare
Traded in other countries / regions
603309.China IPO Date
2015-03-02Description
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.77 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | 2.09 | |||||
| Interest Coverage | 28.53 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.94 | |||||
| Beneish M-Score | -2.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | 4.3 | |||||
| 3-Year EPS without NRI Growth Rate | 1.1 | |||||
| 3-Year Book Growth Rate | 12.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 26.34 | |||||
| Future 3-5Y Total Revenue Growth Rate | 22.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.69 | |||||
| 9-Day RSI | 39.52 | |||||
| 14-Day RSI | 42.49 | |||||
| 6-1 Month Momentum % | 19.98 | |||||
| 12-1 Month Momentum % | -4.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | |||||
| Quick Ratio | 1.49 | |||||
| Cash Ratio | 0.88 | |||||
| Days Inventory | 74.32 | |||||
| Days Sales Outstanding | 45.96 | |||||
| Days Payable | 54.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.06 | |||||
| Dividend Payout Ratio | 0.64 | |||||
| 3-Year Dividend Growth Rate | 30.2 | |||||
| Forward Dividend Yield % | 4.06 | |||||
| 5-Year Yield-on-Cost % | 11.79 | |||||
| 3-Year Average Share Buyback Ratio | -4.1 | |||||
| Shareholder Yield % | -3.65 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.43 | |||||
| Operating Margin % | 18.48 | |||||
| Net Margin % | 14.64 | |||||
| FCF Margin % | -6.12 | |||||
| ROE % | 11.87 | |||||
| ROA % | 8.08 | |||||
| ROIC % | 11.96 | |||||
| ROC (Joel Greenblatt) % | 28.42 | |||||
| ROCE % | 12.26 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.45 | |||||
| Forward PE Ratio | 12.7 | |||||
| PE Ratio without NRI | 15.62 | |||||
| Shiller PE Ratio | 25.99 | |||||
| Price-to-Owner-Earnings | 64.84 | |||||
| PEG Ratio | 0.95 | |||||
| PS Ratio | 2.35 | |||||
| PB Ratio | 1.98 | |||||
| Price-to-Tangible-Book | 2.68 | |||||
| Price-to-Operating-Cash-Flow | 14.87 | |||||
| EV-to-EBIT | 14.47 | |||||
| EV-to-EBITDA | 14.47 | |||||
| EV-to-Revenue | 2.63 | |||||
| EV-to-FCF | -42.11 | |||||
| Price-to-Projected-FCF | 1.74 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.66 | |||||
| Price-to-Graham-Number | 1.34 | |||||
| Price-to-Net-Current-Asset-Value | 174.57 | |||||
| Earnings Yield (Greenblatt) % | 6.91 | |||||
| FCF Yield % | -2.48 | |||||
| Forward Rate of Return (Yacktman) % | 7.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Well Lead Medical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,471.047 | ||
| EPS (TTM) (Â¥) | 0.74 | ||
| Beta | 0.89 | ||
| Volatility % | 36.29 | ||
| 14-Day RSI | 42.49 | ||
| 14-Day ATR (Â¥) | 0.405951 | ||
| 20-Day SMA (Â¥) | 12.9155 | ||
| 12-1 Month Momentum % | -4.26 | ||
| 52-Week Range (Â¥) | 8.52 - 14.67 | ||
| Shares Outstanding (Mil) | 292.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Well Lead Medical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Well Lead Medical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Well Lead Medical Co Ltd Frequently Asked Questions
What is Well Lead Medical Co Ltd(SHSE:603309)'s stock price today?
The current price of SHSE:603309 is ¥12.23. The 52 week high of SHSE:603309 is ¥14.67 and 52 week low is ¥8.52.
When is next earnings date of Well Lead Medical Co Ltd(SHSE:603309)?
The next earnings date of Well Lead Medical Co Ltd(SHSE:603309) is .
Does Well Lead Medical Co Ltd(SHSE:603309) pay dividends? If so, how much?
The Dividend Yield %  of Well Lead Medical Co Ltd(SHSE:603309) is 4.06% (As of Today), Highest Dividend Payout Ratio of Well Lead Medical Co Ltd(SHSE:603309) was 0.64. The lowest was 0.21. And the median was 0.39. The  Forward Dividend Yield % of Well Lead Medical Co Ltd(SHSE:603309) is 4.06%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers